SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 26.70-0.8%Jan 23 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bluegreen who wrote (9104)3/11/1999 11:27:00 AM
From: aknahow  Read Replies (1) of 17367
 
Comments on 125 please! My post showed trial based on estimate of 200. My guess is they thought 25% for 100 and 15% for the other 100 producing a target of 40. Yes many other ratios could have been used. But as one will see most logical concepts produce a number close to 40. Many will say that since we don't know how many deaths have already occurred, that the target is of no use. True but this would mean that so far the mortality rate is 39/370 or about 10%. And lets face it they are not just 1 away from the target or they would have waited.

So the issue of standard of care is crucial. Do the Brits really have this fantastic system of care that takes scale 8 and higher patients and cures them while they die in the U.S.????

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News